Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new history entry (version 9) with a Study Status update was added for 2026-05-19, expanding the record’s current-state information. The entry dated 2025-12-23 was removed from the history.SummaryDifference0.4%

- Check16 days agoChange DetectedThe record history now shows a new Revision: v3.5.4, replacing the prior Revision: v3.5.3. This represents a metadata update to the study record's history rather than a change to the study content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page footer’s software revision indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” a change related to the ClinicalTrials.gov site build rather than the underlying study record.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry, v3.5.2, was added to the Record History and the previous v3.5.0 entry was removed.SummaryDifference0.1%

- Check73 days agoChange DetectedRecord History now shows revision v3.5.0 and removes v3.4.3.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry (v3.4.3) was added to the record history, and an older entry (v3.4.2) was removed.SummaryDifference0.1%

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.